VM
VHCP Management Portfolio holdings
AUM
$93M
This Quarter Return
+9.29%
1 Year Return
-10.46%
3 Year Return
+232.85%
5 Year Return
–
10 Year Return
–
AUM
$223M
AUM Growth
+$223M
(+19%)
Cap. Flow
+$30.7M
Cap. Flow
% of AUM
13.81%
Top 10 Holdings %
Top 10 Hldgs %
88.92%
Holding
19
New
2
Increased
2
Reduced
2
Closed
1
Top Buys
1 |
Adverum Biotechnologies
ADVM
|
$42.8M |
2 |
Lipocine
LPCN
|
$3.22M |
3 |
STML
Stemline Therapeutics, Inc.
STML
|
$884K |
Top Sells
1 |
KERX
Keryx Biopharmaceuticals Inc
KERX
|
$10.8M |
2 |
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
|
$8.99M |
3 |
ALXA
ALEXZA PHARMACEUTICALS INC COM STK NEW (DE)
ALXA
|
$412K |
Sector Composition
1 | Healthcare | 57.76% |